RESEARCH-USE BIOSIMILAR ANTIBODY

Brolucizumab

Antibody fragment · Not specified

VEGFANot specifiedRUO

Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer.

TARGETVEGFA
YAntibody fragment
CATALOGSC-BS-694
CATALOG NUMBERSC-BS-694
MOLECULAR WEIGHTApprox. 26.18 kDa
PRODUCT FORMATAntibody fragment

A research-use configuration for comparative antibody studies

Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer.

Brolucizumab is a recombinant research-use antibody directed against VEGFA.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Brolucizumab | StellaCyte